To confirm the role of the MM_Immune subgroup in anti-PD-1 treatment, we utilized the Cancer Genome Atlas (TCGA)-Skin Cutaneous Melanoma (SKCM) dataset, which includes a large cohort of 471 melanoma patients. This evidence concerns the gene PDCD1 and cutaneous melanoma.